Published in Blood on November 15, 1999
Characterization of clonogenic multiple myeloma cells. Blood (2003) 5.35
Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res (2008) 3.57
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis. Blood (2007) 2.91
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood (2006) 2.91
The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo. Am J Hematol (2009) 2.12
Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model. Haematologica (2006) 2.11
Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth. Blood (2008) 2.06
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood (2011) 1.76
Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J Exp Med (2002) 1.63
Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice. J Clin Invest (2004) 1.53
Multiple myeloma cancer stem cells. J Clin Oncol (2008) 1.39
Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest (2001) 1.35
The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype. Clin Cancer Res (2005) 1.33
Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo. J Biol Chem (2009) 1.18
Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines. Br J Haematol (2007) 1.16
Cancer stem cells: controversies in multiple myeloma. J Mol Med (Berl) (2009) 1.15
The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease. Immunol Rev (2003) 1.13
Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts. Leukemia (2007) 1.12
Clinical implication of centrosome amplification in plasma cell neoplasm. Blood (2005) 1.11
The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth. Blood (2009) 1.08
Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone. Stem Cells (2011) 1.07
Cancer stem cells in multiple myeloma. Cancer Lett (2008) 1.06
Stemness of B-cell progenitors in multiple myeloma bone marrow. Clin Cancer Res (2012) 1.06
Imprinting the fate of antigen-reactive B cells through the affinity of the B cell receptor. J Immunol (2006) 1.05
Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma. Haematologica (2010) 1.04
Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth. J Bone Miner Res (2012) 1.03
Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model. Leukemia (2012) 1.01
Immunological dysregulation in multiple myeloma microenvironment. Biomed Res Int (2014) 0.98
Extravasation and homing mechanisms in multiple myeloma. Clin Exp Metastasis (2007) 0.97
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells. Blood (2013) 0.95
Osteoblastogenesis and tumor growth in myeloma. Leuk Lymphoma (2010) 0.93
Human-like mouse models for testing the efficacy and safety of anti-beta2-microglobulin monoclonal antibodies to treat myeloma. Clin Cancer Res (2009) 0.92
The bone marrow stroma in hematological neoplasms--a guilty bystander. Nat Rev Clin Oncol (2011) 0.89
Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone. PLoS One (2010) 0.89
Fact or fiction--identifying the elusive multiple myeloma stem cell. J Hematol Oncol (2013) 0.86
The immune microenvironment of myeloma. Cancer Microenviron (2011) 0.86
Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance. Haematologica (2013) 0.85
The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell. Cancer Microenviron (2010) 0.85
Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies. PLoS One (2013) 0.85
Nonirradiated NOD/SCID-human chimeric animal model for primary human multiple myeloma: a potential in vivo culture system. Am J Pathol (2004) 0.84
Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4. BMC Cancer (2011) 0.83
Multiple myeloma cancer stem cells. Oncotarget (2016) 0.82
Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma. PLoS One (2012) 0.82
Deregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitors. J Immunol (2008) 0.82
Progress in myeloma stem cells. Am J Blood Res (2011) 0.81
N-cadherin impedes proliferation of the multiple myeloma cancer stem cells. Am J Blood Res (2013) 0.81
Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease. Br J Haematol (2009) 0.80
Immunotherapy based on bispecific T-cell engager with hIgG1 Fc sequence as a new therapeutic strategy in multiple myeloma. Cancer Sci (2015) 0.80
Myeloma Cell Dynamics in Response to Treatment Supports a Model of Hierarchical Differentiation and Clonal Evolution. Clin Cancer Res (2016) 0.79
High throughput quantitative reverse transcription PCR assays revealing over-expression of cancer testis antigen genes in multiple myeloma stem cell-like side population cells. Br J Haematol (2014) 0.78
Cancer stem cells: relevance to SCT. Bone Marrow Transplant (2009) 0.77
NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity. Exp Hematol (2013) 0.77
The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myeloma. PLoS One (2015) 0.76
Cancer stem cells of differentiated B-cell malignancies: models and consequences. Cancers (Basel) (2011) 0.75
Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow. BMC Cancer (2015) 0.75
Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations. Blood (1998) 2.60
Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med (1999) 2.39
Undergraduate education in emergency medicine. Ann Emerg Med (1990) 2.36
Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc Natl Acad Sci U S A (2001) 2.27
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25
Herpesvirus infections in the acquired immune deficiency syndrome. JAMA (1984) 2.25
Remodelling of adipose tissue during experimental omental adhesion formation. Br J Surg (2008) 2.02
Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc Natl Acad Sci U S A (1989) 1.97
Latex allergies in dentistry: recognition and recommendations. J Can Dent Assoc (1997) 1.95
Challenges to implementation of the new Coroners' (Amendment) Rules 2005: experience from a tertiary paediatric pathology centre. Med Sci Law (2007) 1.92
Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood (1999) 1.89
Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci U S A (2001) 1.63
Selecting the future doctors: the role of graduate medical programmes. Intern Med J (2005) 1.61
Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry (1999) 1.60
Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood (1996) 1.56
Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. Blood (2000) 1.52
Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood (1994) 1.52
Emergency medicine--no longer a casualty. Med J Aust (1989) 1.50
The use of external data sources and ratio estimation to improve estimates of hardcore drug use from the NHSDA. NIDA Res Monogr (1997) 1.49
Increased emphasis of medically necessary oral health care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 1.42
[The evidence of human immunodeficiency virus infection in the seronegative subjects of high-risk groups]. Med Clin (Barc) (1991) 1.40
High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood (2000) 1.39
Preventable death studies: an inappropriate tool for evaluating trauma systems. Aust N Z J Surg (1997) 1.39
Does care exclude cure in palliative care? J Palliat Care (1986) 1.38
Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood (1993) 1.34
Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry (2000) 1.33
Compliance with infection control procedures in a dental hospital clinic. Br Dent J (1992) 1.32
Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology (2011) 1.32
Chromosome 13 homozygosity in osteosarcoma without retinoblastoma. Am J Hum Genet (1986) 1.30
Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood (1999) 1.30
An immunoassay to detect human müllerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab (1990) 1.26
Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res (1999) 1.26
The esterase activity in megaloblasts, leukaemic and normal haemopoietic cells. Br J Haematol (1968) 1.25
VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma. Leukemia (2008) 1.25
Plasma cell myeloma--new biological insights and advances in therapy. Blood (1989) 1.25
Deficient DNA repair in human progeroid cells. Proc Natl Acad Sci U S A (1973) 1.20
Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr (1992) 1.16
Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood (1993) 1.16
The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone. Exp Hematol (1998) 1.11
The LN54 radiation hybrid map of zebrafish expressed sequences. Genome Res (2001) 1.11
Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma. Cancer Res (1998) 1.10
Human fear-related motor neurocircuitry. Neuroscience (2007) 1.07
Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg (1995) 1.03
Mutagen-induced diploid human lymphoblast variants containing altered hypoxanthine guanine phosphoribosyl transferase. Somatic Cell Genet (1977) 1.02
Adult inpatient alcoholics: physical exercise as a treatment intervention. J Stud Alcohol (1988) 1.02
Effects of long ultraviolet rays on human skin: photoprotective or photoaugmentative? J Invest Dermatol (1972) 1.00
Solitary fibrous tumor of the lower urogenital tract: a report of five cases involving the seminal vesicles, urinary bladder, and prostate. Hum Pathol (2000) 0.99
Dose-dependent inhibition of cold air-induced bronchoconstriction by atropine. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.99
Deletion of the retinoblastoma gene in multiple myeloma. Leukemia (1994) 0.99
Establishment of cell lines of uveal melanoma. Methodology and characteristics. Invest Ophthalmol Vis Sci (1984) 0.99
Distinguishing homozygous and heterozygous cystic fibrosis fibroblasts from normal cells by differences in sodium transport. N Engl J Med (1981) 0.99
Rectal intussusception in symptomatic patients is different from that in asymptomatic volunteers. Br J Surg (2005) 0.99
Kaposi's sarcoma and disseminated tuberculosis in HIV-negative individual. Lancet (1992) 0.97
Expression of alpha(v)beta6 integrin in oral leukoplakia. Br J Cancer (2000) 0.96
Application of UMLS indexing systems to a WWW-based tool for indexing of digital images. Proc AMIA Annu Fall Symp (1997) 0.96
The molecular basis of the action of chloroquine in porphyria cutanea tarda. J Invest Dermatol (1973) 0.96
Interaction of sulfur dioxide and dry cold air in causing bronchoconstriction in asthmatic subjects. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.95
In vitro radiosensitivity of human dipliod fibroblasts derived from patients with unusual clinical responses to radiation. Radiology (1976) 0.95
Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer (2001) 0.95
Effect of fragile X status categories and FMRP deficits on cognitive profiles estimated by robust pedigree analysis. Am J Med Genet A (2003) 0.94
Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States. Haemophilia (2012) 0.94
Increased resistance of cystic fibrosis fibroblasts to ouabain toxicity. Proc Natl Acad Sci U S A (1977) 0.94
The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab (1993) 0.93
Tolerance to sulfur dioxide-induced bronchoconstriction in subjects with asthma. Environ Res (1983) 0.93
The influence of psychological stress on periodontal disease. J West Soc Periodontol Periodontal Abstr (2000) 0.92
Oral mucosal Langerhans' cells as target, effector and vector in HIV infection. J Oral Pathol Med (2000) 0.92
Murine macrophage mannose receptor promoter is regulated by the transcription factors PU.1 and SP1. Blood (1997) 0.91
Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells. Br J Haematol (2000) 0.91
Allergic contact photodermatitis to para-aminobenzoic acid. Arch Dermatol (1978) 0.88
Preparation of individual human diploid fibroblasts and study of ion transport. Am J Physiol (1985) 0.88
Ketamine and xylazine combinations for short-term immobilization of wild variable flying foxes (Pteropus hypomelanus). J Zoo Wildl Med (2008) 0.88
The drug abuse treatment gap: recent estimates. Health Care Financ Rev (1997) 0.87
An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 0.87
Inherent cellular radiosensitivity of human tumors of varying clinical curability. AJR Am J Roentgenol (1976) 0.87
Characterization and radiobiologic parameters of medulloblastoma in vitro. Cancer (1977) 0.87
Orofacial pain in cancer: part I--mechanisms. J Dent Res (2007) 0.87
Age differences in understanding of disease causality: AIDS, colds, and cancer. Child Dev (1993) 0.86
Impaired glutathione peroxidase activity accounts for the age-related accumulation of hydrogen peroxide in activated human neutrophils. J Gerontol A Biol Sci Med Sci (1998) 0.86
Analysis of HGPRT- CRM+ human lymphoblast mutants. Somatic Cell Genet (1979) 0.86
Occult hepatitis B infection in blood donors. Vox Sang (2008) 0.86
Expression of an ouabain resistance gene in transfected cells. Ouabain treatment induces a K+-transport system. J Biol Chem (1985) 0.86
Inositol 1,4,5-trisphosphate stimulates phosphorylation of a 62,000-dalton protein in monkey fibroblast and bovine brain cell lysates. J Biol Chem (1984) 0.86
Local tumor recurrence or emergence of a new primary lesion? A molecular analysis. J Oral Pathol Med (1999) 0.86
Sulfur dioxide-induced bronchoconstriction in freely breathing, exercising, asthmatic subjects. Am Rev Respir Dis (1983) 0.86
The effect of prostaglandins on the multiplication and cell-to-cell spread of herpes simplex virus type 2 in vitro. Am J Obstet Gynecol (1982) 0.86
Oral lesions in HIV-positive dental patients--one more argument for tobacco smoking cessation. Oral Dis (2007) 0.86
Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo. Cancer Res (1992) 0.86
Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia. Cancer Chemother Pharmacol (1984) 0.85
In vitro cellular radiosensitivity of human malignant tumors. Eur J Cancer (1976) 0.85
A technique for developing established cell lines from human osteosarcomas. In Vitro (1976) 0.85
Oversight and monitoring of blood safety in the United States. Vox Sang (1999) 0.85
Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma. Leuk Lymphoma (1998) 0.85
Current and proposed biologic markers in prostate cancer. J Cell Biochem Suppl (1992) 0.85
A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab Invest (2001) 0.84
Assessment by gene amplification and serological markers of transmission of HIV-1 from hemophiliacs to their sexual partners and secondarily to their children. J Acquir Immune Defic Syndr (1990) 0.84
Correlated flow cytometric analysis of H-ras p21 and nuclear DNA in multiple myeloma. Blood (1988) 0.84
Effect of exercise rate and route of inhalation on sulfur-dioxide-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis (1983) 0.83
Enhanced dexamethasone resistance in cystic fibrosis cells: potential use for heterozygote detection and prenatal diagnosis. Science (1978) 0.83